Jupiter Life Line Hospitals' Q2 FY 2025-26 Quarterly Results

Result Summary

• Jupiter Life Line Hospitals Ltd reported a 12.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 22.0%.
• Its expenses for the quarter were up by 10.6% QoQ and 25.7% YoY.
• The net profit increased 31.0% QoQ and increased 11.6% YoY.
• The earnings per share (EPS) of Jupiter Life Line Hospitals Ltd stood at 8.75 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Jupiter Life Line Hospitals Ltd is a prominent player in the healthcare sector, primarily engaged in providing comprehensive medical services through its network of hospitals. The company is known for offering a wide range of healthcare services including general medicine, surgery, and specialty treatments. The company is part of the broader healthcare industry, which is characterized by its essential services and consistent demand. Recent developments in this industry often focus on advancements in medical technology, patient care, and regulatory changes, but specific recent developments concerning Jupiter Life Line Hospitals Ltd were not included in the provided data.

Revenue

In the second quarter of the fiscal year 2026, Jupiter Life Line Hospitals Ltd reported a total income of ₹404.90 crores. This represents a quarter-over-quarter (QoQ) increase of 12.3% compared to ₹360.49 crores in Q1FY26 and a year-over-year (YoY) growth of 22.0% from ₹332.02 crores in Q2FY25. The financial performance in terms of revenue indicates a notable increase over both the previous quarter and the same period last year. This growth reflects the company's ability to enhance its income generation capabilities over time.

Profitability

During Q2FY26, Jupiter Life Line Hospitals Ltd achieved a profit before tax (PBT) of ₹74.22 crores, which is a 20.6% increase from ₹61.53 crores in the previous quarter and a 7.7% rise from ₹68.91 crores in Q2FY25. The profit after tax (PAT) for the same period was ₹57.47 crores, marking a substantial QoQ growth of 31.0% from ₹43.88 crores in Q1FY26 and an 11.6% YoY increase from ₹51.51 crores in Q2FY25. The earnings per share (EPS) for Q2FY26 was ₹8.75, up 30.8% QoQ from ₹6.69 and 11.3% YoY from ₹7.86. These figures illustrate a significant improvement in profitability measures compared to both the previous quarter and the same quarter of the prior year. The tax expense for Q2FY26 was ₹16.74 crores, showing a reduction of 5.2% QoQ from ₹17.66 crores and a 3.8% decrease YoY from ₹17.40 crores.

Operating Metrics

The total expenses for Jupiter Life Line Hospitals Ltd in Q2FY26 amounted to ₹330.68 crores, showing an increase of 10.6% from ₹298.96 crores in the previous quarter and a 25.7% rise from ₹263.11 crores in Q2FY25. Despite the increase in expenses, the company's revenue growth outpaced the rise in expenses, contributing to the improved profitability. The analysis of these operating metrics highlights the company's ability to manage its operational costs while enhancing its income, although the detailed breakdown of these expenses is not available in the provided data.